临床试验

RNS System LGS Feasibility Study

NCT：NCT05339126 · ACTIVE_NOT_RECRUITING

NCT编号NCT05339126

状态ACTIVE_NOT_RECRUITING

开始日期2022-10-04

完成时间2026-12-31

SponsorNeuroPace (INDUSTRY)

First posted2022-04-21

Last updated2026-09-15

简要摘要

To generate preliminary safety and effectiveness data for brain-responsive neurostimulation of thalamocortical networks as an adjunctive therapy in reducing the frequency of generalized seizures in individuals 12 years of age or older with Lennox Gastaut Syndrome (LGS) who are refractory to antiseizure medications. The intent is to determine the feasibility and the optimal design of a subsequent pivotal study in order to expand the indication for use for the RNS System as a treatment for patients with medically intractable LGS.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。